Journal of Pharmaceutical Innovation

, Volume 7, Issue 1, pp 1–1 | Cite as

The Journal of Pharmaceutical Innovation: a Forum for Discussion of Science-Based Strategy and Regulatory Requirements

  • James K. DrennenIIIEmail author

I am very pleased to let our readers know that the Journal of Pharmaceutical Innovation has been selected for coverage in the products and services of Thomson Reuters. Beginning with V.4 (1) 2009, the journal will be indexed and abstracted in Science Citation Index Expanded (also known as SciSearch®) and Journal Citation Reports/Science Edition. The journal should receive its first impact factor during 2012! I offer a sincere thank you to all who have helped us reach this goal, including authors, referees, readers/subscribers, editorial advisory board members, and Springer personnel. I look forward to a successful year for the journal during 2012.

In the current issue, readers will find a variety of interesting papers, ranging from a review of analytical methods used in analyzing solid dispersions to a perspective article proposing strategies for verification of design spaces. The issue of defining and verifying design spaces is an important current topic in our industry and one that requires continued discussion. While the present article on design space is published as a science-based strategy paper, the topic will no doubt generate further dialogue regarding the suitability of such approaches for regulatory filing requirements. The Journal of Pharmaceutical Innovation is an ideal forum for the publication and discussion of such topics, and I invite our readers to submit research papers, case studies, and perspective articles to continue the exchange of ideas regarding these important issues.

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Duquesne UniversityPittsburghUSA

Personalised recommendations